ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference

Quantum-Si Incorporated (NASDAQ: QSI):

WHAT: The Protein Sequencing Company™, Quantum-Si Incorporated, will showcase its Next-Generation Protein Sequencing™ instrument, Platinum®, and recent enhancements at the 20th Anniversary US HUPO Conference in Portland, Oregon on March 9-13. Additionally, researchers will present data from Platinum and highlight how protein sequencing on the benchtop instrument is providing deeper insights into proteins through streamlined workflows.

WHY: Quantum-Si brings the groundbreaking power of single-molecule proteomics with the first-to-market Next-Generation Protein Sequencer™, the Platinum instrument, to every lab, everywhere.

WHO AND WHEN:

  • Justyna Fert-Bober, Ph.D., Assistant Professor, Dept of Cardiology, Smidt Heart Institute, Cedars Sinai and Kenneth Skinner, Ph.D., Quantum-Si Staff Scientist, present the Breakfast Seminar: Joining Forces: Next-Generation Protein Sequencing™ and Mass Spectrometry to Power PTM Analysis
    • Get the latest updates on applications and workflows and discover the power of using Kinetic Signatures to sequence proteins and detect changes in the proteome, including PTM analysis.
    • Wednesday, March 13 | 7:15-8:15a.m. PT
  • Dr. Fert-Bober, Ph.D. will also participate in the panel discussion, Post-Translational Modifications to Proteoforms
    • Learn how the Fert-Bober lab at Cedars Sinai distinguished citrullinated arginine from non-citrullinated arginine using Quantum-Si’s Platinum.
    • Tuesday, March 12 | Parallel Session 7
  • Poster Presentations:
    • Kendrick Nguyen, Ph.D., Quantum-Si Product Application Specialist presents: Quantum-Si’s Next-Generation Protein Sequencer™ Enables Protein Detection and Peptide Characterization
      • Poster Number: P01.13
      • Monday, March 11 | 1:30-3:00p.m. PT
    • Edgar Manriquez-Sandoval of Johns Hopkins University presents: Enzymatic Addition of C-Terminal Azides to Polypeptides for Single-Molecule Sequencing
      • Poster Number: P515
      • Monday, March 11 | 1:30-3:00pm PT
  • Additionally, Quantum-Si will showcase Platinum’s groundbreaking technology at Booth #315 during US HUPO exhibition hours on March 10, 11, and 12.

WHERE: The 2024 US HUPO Conference is being held at the Hyatt Regency Portland, 375 NE Holladay St, Portland, OR 97232

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.22
+21.36 (9.58%)
AAPL  270.37
-1.03 (-0.38%)
AMD  256.12
+1.28 (0.50%)
BAC  53.45
+0.42 (0.79%)
GOOG  281.82
-0.08 (-0.03%)
META  648.35
-18.12 (-2.72%)
MSFT  517.81
-7.95 (-1.51%)
NVDA  202.49
-0.40 (-0.20%)
ORCL  262.61
+5.72 (2.23%)
TSLA  456.56
+16.46 (3.74%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.